Husi Kata, Szabó Roxána, Pinczés László Imre, Földeák Dóra Melinda, Dudley Réka, Szomor Árpád, . . . Miltényi Zsófia. (2023). Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary.
Chicago Style (17th ed.) CitationHusi Kata, et al. Improved Survival of Autologous Stem Cell Transplantation in Primary Refractory and Relapsed Hodgkin Lymphoma in the Brentuximab Vedotin Era - Real-world Data from Hungary. 2023.
MLA idézésHusi Kata, et al. Improved Survival of Autologous Stem Cell Transplantation in Primary Refractory and Relapsed Hodgkin Lymphoma in the Brentuximab Vedotin Era - Real-world Data from Hungary. 2023.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..